Nisa Investment Advisors LLC lessened its position in shares of The Beauty Health Company (NASDAQ:SKIN – Get Rating) by 48.5% in the first quarter, according to its most recent filing with the SEC. The firm owned 1,700 shares of the company’s stock after selling 1,600 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Beauty Health were worth $29,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in SKIN. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in Beauty Health during the 4th quarter valued at approximately $273,000. Envestnet Asset Management Inc. acquired a new stake in Beauty Health during the 4th quarter valued at approximately $321,000. Blair William & Co. IL acquired a new stake in Beauty Health during the 4th quarter valued at approximately $390,000. Handelsbanken Fonder AB acquired a new stake in shares of Beauty Health during the 4th quarter worth approximately $394,000. Finally, Brown Advisory Inc. acquired a new stake in shares of Beauty Health during the 4th quarter worth approximately $404,000. Institutional investors and hedge funds own 72.01% of the company’s stock.
Beauty Health Trading Down 2.6 %
NASDAQ:SKIN opened at $13.32 on Monday. The company has a debt-to-equity ratio of 2.14, a current ratio of 14.25 and a quick ratio of 13.57. The firm has a 50-day moving average of $13.02 and a 200-day moving average of $14.34. The company has a market cap of $1.99 billion, a PE ratio of -3.92 and a beta of 1.67. The Beauty Health Company has a one year low of $9.94 and a one year high of $30.17.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the stock. DA Davidson reduced their price objective on shares of Beauty Health from $35.00 to $24.00 in a research report on Wednesday, May 11th. Piper Sandler reduced their price objective on shares of Beauty Health from $24.00 to $22.00 and set an “overweight” rating for the company in a research report on Friday, July 8th. Canaccord Genuity Group reduced their price objective on shares of Beauty Health from $22.00 to $20.00 in a research report on Thursday, June 30th. Finally, Canaccord Genuity Group reduced their price objective on shares of Beauty Health from $22.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, June 30th. One research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.78.
Beauty Health Profile
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
- Get a free copy of the StockNews.com research report on Beauty Health (SKIN)
- Use These To Find Your Stock’s Support and Resistance Levels
- Is Boeing Stock is Ready for Lift-Off ?
- Elon Musk is Out, But Should You Be In Twitter Stock?
- 3 Earnings Announcements That Could Surprise
- Twitter’s Up For Third Week In A Row: What’s Next For The Stock?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.